PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center of Research of Immunopathology and Rare Diseases, Coordinating Center of Piemonte and Valle d\'Aosta Network for Rare Diseases, Department of Clinical and Biological Sciences, University of Turin and S. Giovanni Bosco Hospital, Turin, Italy.\', \'Nephrology and Dialysis Unit, S. Giovanni Bosco Hospital and University of Turin, Turin, Italy.\', \'Hematology Division, S. Giovanni Bosco Hospital, Turin, Italy.\', \'AO Ordine Mauriziano, Turin, Italy.\', \'Internal Medicine, San Luigi Gonzaga Hospital Orbassano, Turin, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.687534
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34220842
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Antiphospholipid Antibodies and Infection: Non Nova Sed Nove.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34220842>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34220842>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all